Proteomic study of urine to discover novel biomarkers for human prostate cancer

尿液蛋白质组学研究发现人类前列腺癌的新型生物标志物

• 批准号: LP110100384
• 负责人: Dr Paul Cozzi
• 金额: $ 10.08万
• 依托单位: The University of New South Wales
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2018-08-30
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP110100384
• 关键词: Proteomic; study; urine; discover; novel

The purpose of this project is to identify novel markers in the urine of patients with prostate cancer. These biomarkers may ultimately prove useful in the development of novel diagnostic tools for the management of this disease.

本项目的目的是在前列腺癌患者的尿液中确定新的标志物。这些生物标记物最终可能被证明在开发治疗这种疾病的新诊断工具方面有用。